Related Experiment Videos
Drug interactions during metabolism in the liver
Naunyn-Schmiedeberg'S Archives of Pharmacology
|March 31, 1977
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Regulatory Consequences of "Brexit" for the Development of Medicinal Products.
Clinical pharmacology and therapeutics·2017
Regulatory review: How do agencies ensure the quality of decision making?
Clinical pharmacology and therapeutics·2013
Advancing the science of medicines regulation: the role of the 21st-century medicines regulator.
Clinical pharmacology and therapeutics·2012
The challenges of orphan drugs and orphan diseases: real and imagined.
Clinical pharmacology and therapeutics·2012
European perspective on risk management and drug safety.
Clinical pharmacology and therapeutics·2011
Medicines regulation and health technology assessment.
Clinical pharmacology and therapeutics·2010
Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.
Naunyn-Schmiedeberg's archives of pharmacology·2026
Synergic anticancer effects of morin hydrate and sorafenib delivered via polymeric iron oxide nanoparticles for the treatment of triple-negative breast cancer.
Naunyn-Schmiedeberg's archives of pharmacology·2026
Exploring the role of inflammatory cytokines in obesity-mediated MASLD development and drug target identification.
Naunyn-Schmiedeberg's archives of pharmacology·2026
Evaluation of colostrum-coated ZnO nanoparticles (C-ZnONPs) in attenuating valproic acid-induced prenatal toxicity.
Naunyn-Schmiedeberg's archives of pharmacology·2026
Postoperative Nocardia cyriacigeorgica infection after glioblastoma resection: correlating metagenomic next-generation sequencing with conventional microbiology.
Naunyn-Schmiedeberg's archives of pharmacology·2026
Disproportionality analysis of adverse events associated with tyrosine kinase inhibitors in gastrointestinal stromal tumors in the FDA adverse event reporting system.
Naunyn-Schmiedeberg's archives of pharmacology·2026
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease·2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Therapeutic advances in neurological disorders·2026